Related Experiment Video
Updated: Apr 5, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.3K
[New progress in prostate cancer biomarker research]
Min Qu1, Shancheng Ren1, Yinghao Sun2
1Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|August 14, 2015
Summary
Prostate cancer requires better biomarkers for accurate diagnosis and molecular classification. Advanced techniques like high-throughput sequencing are identifying promising new markers beyond prostate specific antigen (PSA).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer presents significant challenges in diagnosis, treatment, and prognosis due to its heterogeneity.
- Current diagnostic methods like prostate specific antigen (PSA) have limitations, leading to unnecessary biopsies.
Purpose of the Study:
- To highlight the urgent need for novel prostate cancer biomarkers.
- To discuss the potential of molecular markers for improving diagnosis and molecular classification.
Main Methods:
- Review of emerging diagnostic and classification strategies for prostate cancer.
- Exploration of high-throughput sequencing techniques for biomarker discovery.
Main Results:
- Long non-coding RNAs, single nucleotide polymorphisms, and fusion genes show promise in enhancing diagnostic accuracy.
- DNA copy number variations and RNA-based markers (small RNAs, lncRNAs) are linked to cancer progression and molecular classification.
Conclusions:
- While still in early stages, high-throughput sequencing and molecular biotechniques are crucial for discovering effective prostate cancer biomarkers.
- New biomarkers are essential for guiding biopsy decisions, treatment selection, and patient follow-up.
